美容医療の世界市場予測（～2021）： 脂肪吸引、セリュライト低減、脂肪低減、皮膚引き締め、豊胸術、ボトックス、皮膚充填剤、タトゥー除去、スレッドリフト、レーザー脱毛...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Medical Aesthetics Market Definition
1.3 Medical Aesthetics Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primary Interviews
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions and Limitations
2.4.1 Assumptions
2.4.2 Limitations

3 Executive Summary (Page No. – 27)
3.1 Introduction
3.2 Conclusion

4 Premium Insights (Page No. – 32)
4.1 Medical Aesthetics Market Overview
4.2 Medical Aesthetics Market: Product Benchmarking (2016–2021)
4.3 Medical Aesthetics Market By Product 2016 vs 2021 (USD Million)
4.4 Medical Aesthetics Market By End User 2016 vs 2021
4.5 Medical Aesthetics Market By Region (Market Size and Growth Rate)

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Medical Aesthetics Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Adoption of Minimally Invasive and Noninvasive Aesthetic Procedures
5.2.1.2 Growth in Aging Population
5.2.1.3 Increasing Awareness of Cosmetic Procedures
5.2.1.4 Technological Advancements in Energy-Based Aesthetic Devices
5.2.1.5 Increasing Demand for Aesthetic Treatments Among the Male Population
5.2.1.6 Availability of User-Friendly Aesthetic Devices
5.2.2 Restraints
5.2.2.1 Stringent Safety Regulations for Aesthetic Procedures
5.2.2.2 Low Focus of Market Players on Development of Medical Aesthetic Devices for Dermatological Conditions
5.2.3 Opportunities
5.2.3.1 Emerging Markets Offer Lucrative Growth Opportunities
5.2.3.2 Development of Low-Cost Medical Aesthetic Devices
5.2.3.3 Growing Adoption of Home-Use Aesthetic Devices
5.2.4 Challenges
5.2.4.1 Sustainability of Players in the Highly Competitive Market
5.2.4.2 Rising Adoption of Branded Beauty and Cosmetic Products
5.2.4.3 Product Recalls
5.2.4.4 Social Stigmas Associated With Cosmetic Treatments

6 Industry Insights (Page No. – 47)
6.1 Introduction
6.2 Key Industry Trends
6.2.1 Growing Importance of Social Media in the Medical Aesthetics Industry
6.2.2 Industry Consolidation
6.2.3 Shift From Reconstructive Aesthetic Surgeries to Cosmetic Treatment in the U.S.
6.2.4 Burning Issues
6.2.4.1 Stringent Regulatory Standards
6.2.4.2 Reimbursement
6.2.5 Technological Advancements in Aesthetic Procedures
6.3 Porter’s Five Forces Analysis
6.3.1 Threat of New Entrants
6.3.2 Threat of Substitutes
6.3.3 Bargaining Power of Suppliers
6.3.4 Bargaining Power of Buyers
6.3.5 Intensity of Competitive Rivalry

7 Medical Aesthetics Market By Product (Page No. – 54)
7.1 Introduction
7.2 Facial Aesthetic
7.2.1 Dermal Fillers
7.2.2 Botulinum Toxin
7.2.3 Microdermabrasion
7.2.4 Chemical Peels
7.3 Energy-Based Devices
7.3.1 Nonsurgical Fat Reduction Devices
7.3.2 Nonsurgical Skin Tightening Devices
7.3.3 Cellulite Reduction Devices
7.3.4 Liposuction Devices
7.4 Breast Implants
7.4.1 Silicone Breast Implants
7.4.2 Saline Breast Implants
7.4.3 Cohesive Semisolid Gel Breast Implants
7.5 Physician-Dispensed Cosmeceuticals and Skin Lighteners
7.6 Laser Resurfacing Devices
7.7 Physician-Dispensed Eyelash Products
7.8 Laser Hair Removal Devices
7.9 Tattoo Removal Devices
7.1 Thread Lift Products

8 Medical Aesthetics Market By End User (Page No. – 77)
8.1 Introduction
8.2 Clinics and Medical Spas
8.3 Beauty Centers

9 Global Medical Aesthetics Market By Region (Page No. – 81)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Growing Volume of Aesthetic Procedures
9.2.1.2 FDA Approval for Home-Use Aesthetics Devices
9.2.1.3 Rapidly Increasing Aging and Obese Population
9.2.1.4 Increasing Demand for Aesthetic Procedures Among Male Population
9.2.1.5 Launch of Innovative Aesthetic Products
9.2.1.6 Rich Research Pipeline
9.2.1.7 Entry of Substandard and Unapproved Products in the Supply Chain Hindering Market Growth
9.2.1.8 Lack of Reimbursement and High Cost of Aesthetic Procedures
9.2.2 Canada
9.3 Europe
9.3.1 Launch of Novel Aesthetic Products
9.3.2 High Use of Dermal Fillers in Europe
9.3.3 Conferences and Training Programs
9.3.4 Growing Investments By Market Players to Develop Aesthetic Products
9.3.5 Dearth of Pertinent Regulatory Guidelines
9.3.6 Slow Market Growth Due to Economic Crisis and Reimbursement Issues
9.3.6.1 Germany
9.3.6.2 France
9.3.6.3 U.K.
9.3.6.4 Rest of Europe
9.4 Asia-Pacific
9.4.1 Rise in Middle Class and Purchasing Power in the Region
9.4.2 Growing Inclination Towards Noninvasive & Minimally Invasive Surgeries
9.4.3 Growing Preference for Aesthetic Surgery in South Korea
9.4.4 Increasing Focus of Global Players on the Asia-Pacific Aesthetics Market
9.4.5 Launch of Novel Aesthetic Products
9.4.6 Growing Uses of Neurotoxins
9.4.7 Lack of Reimbursement
9.5 Rest of the World
9.5.1 Rise in Medical Tourism
9.5.2 Rising Number of Aesthetic Procedures
9.5.3 Increasing Number of Surgical Procedures in Brazil
9.5.4 Growing Focus of Global Players on the Latin American Region
9.5.5 Presence of Leading Aesthetic Devices Manufacturers in Israel
9.5.6 Weak Economy and Low Consumer Buying Power
9.5.7 Shortage of Plastic Surgeons in the Middle East and Africa

10 Competitive Landscape (Page No. – 121)
10.1 Introduction
10.2 Market Share Analysis
10.2.1 Facial Aesthetics Market
10.2.2 Energy-Based Devices Market
10.2.3 Breast Implants Market
10.3 Competitive Situation and Trends
10.3.1 Product Launches and Approvals
10.3.2 Mergers and Acquisitions
10.3.3 Agreements Partnerships and Collaborations
10.3.4 Geographical Expansions
10.3.5 Other Developments

11 Company Profiles (Page No. – 130)
(Overview Products and Services Financials Strategy & Development)*
11.1 Introduction
11.2 Allergan PLC (A Division of Actavis PLC)
11.3 Solta Medical Inc. (A Division of Valeant Pharmaceuticals International Inc.)
11.4 Syneron Medical Ltd.
11.5 Photomedex Inc.
11.6 Cynosure Inc.
11.7 Lumenis Ltd.
11.8 Johnson & Johnson
11.9 Zeltiq Aesthetics Inc.
11.10 Merz Aesthetics Inc. (A Division of Merz Pharma GmbH & Co. KGaA)
11.11 Galderma S.A. (A Subsidiary of Nestlé S.A.)
11.12 Alma Lasers Ltd. (Acquired By Shanghai Fosun Pharmaceutical (Group) Co. Ltd.)

*Details on Overview Products and Services Financials Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 163)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details